parkinson glutathione oxidative ipsc crispr

parkinson glutathione oxidative ipsc crispr Decreases Parkinsonism‐Induced Ferroptosis and Stress Through the Inhibition of the TRPM2 Channel in Neuronal Cells - Güzel - 2025 - Pharmacology Research & Perspectives Non-invasive CRISPR/Cas9 nanocapsules specifically edit

Name: parkinson glutathione oxidative ipsc crispr Decreases Parkinsonism‐Induced Ferroptosis and Stress Through the Inhibition of the TRPM2 Channel in Neuronal Cells - Güzel - 2025 - Pharmacology Research & Perspectives Non-invasive CRISPR/Cas9 nanocapsules specifically edit
Brand: equiscorp.hu
SKU: 21171386816
Price: 23.22 USD
Availability: InStock
Rating: 4.216 (21 reviews)

Non invasive CRISPR Cas9 nanocapsules specifically edit synuclein for effective Parkinson's disease treatment ScienceDirect Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether phospholipid membrane composition: Cell Reports Oxidative stress monitoring in iPSC derived motor neurons using genetically encoded biosensors of H2O2 Scientific Reports CRISPR Cas9 assisted stem cell therapy in Parkinson's disease Biomaterials Research Springer Nature Link

SKU: 21171386816 · From equiscorp.hu

4.2

USD23.22 USD66.22

Pay in 4 interest-free payments of $5.80 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

demonstrated that in CRC liver metastasis, ALDOB enhances tumor cell growth by facilitating fructose metabolism, allowing tumor cells to adapt their metabolic pathways to utilize available sugar sources in the liver's new microenvironment through the action of ALDOB